Browse by Author Shek, HP
|
|
|
|
|
| Title | Author(s) | Year | View Count |
 | Implications of the use of eukaryotic translation initiation factor 5A (eIF5A) for prognosis and treatment of hepatocellular carcinoma | Shek, HP; Fatima, S; Lee, NPY | 2012 | 23 |
 | Tumorigenic properties of serine peptidase inhibitor, Kazal type 1 (SPINK1) in hepatocellular carcinoma (Poster & Abstract) | Shek, HP; Lee, NPY | 2011 | 26 |
| Targeting serine peptidase inhibitor, Kazal type 1 (SPINK1) as a potential treatment for hepatocellular carcinoma (Abstract) | Shek, HP; Luk, JMC; Lee, NPY | 2011 | 64 |
| Tumorigenic properties of serine peptidase inhibitor, Kazal type 1 (SPINK1) in hepatocellular carcinoma (Abstract) | Shek, HP; Lee, NPY | 2011 | 55 |
| The role of serine peptidase inhibitor, Kazal type I (SPINK1) in hepatocellular carcinoma (Poster Presentation) | Shek, HP; Luk, JMC; Kwong, A; Lee, NPY | 2010 | 78 |
|
|
|
|
